Login / Signup

Hepatic fibrosis is associated with an increased rate of decline in bone mineral density in men with nonalcoholic fatty liver disease.

Ji Won YoonMin Joo KimGoh-Eun ChungJong In YangJeong Yoon YimJin Ju KimSun Mie KimMin Sun Kwak
Published in: Hepatology international (2021)
This study is a retrospective observational study and is not a drug trial. There was no need for clinical trial registration.
Keyphrases
  • bone mineral density
  • clinical trial
  • postmenopausal women
  • body composition
  • study protocol
  • phase ii
  • phase iii
  • open label
  • liver fibrosis
  • double blind
  • adverse drug